What’s new in Vapour?
It is recognised by many public health bodies that cigarette smokers who switch completely to vaping are likely to reduce their risk of developing smoking-related diseases and premature death.
In order to make an informed decision, smokers need access to evidence-based information. To coincide with World Vape Day, we published a comprehensive review1 of the scientific evidence for vaping products, their potential health effects, and their role in Tobacco Harm Reduction. It’s a summary of more than 300 peer-reviewed scientific papers and other evidence published by around 50 institutions over the past decade.
The review showed that, over the past decade, the number of people who incorrectly believe vaping is as harmful or more harmful than smoking conventional cigarettes has risen in the UK, Europe, and the U.S. This is despite several scientific reviews2,3,4 published in the same period showing that vaping products manufactured in accordance with quality standards present less risk to health than cigarettes.*†
According to adult population modelling studies cited in the review, a significant reduction in premature deaths could be achieved if current smokers switched exclusively to vaping rather than continuing to smoke cigarettes. These modelling studies use population data and simulations to project the health-related outcomes associated with the long-term risks of smoking versus vaping over time.
The review also highlights that vaping products can effectively compete with combustible cigarettes by providing nicotine and the sensorial enjoyment sought by smokers. Therefore, access to high-quality, extensively tested and well-regulated vapour products is crucial. However, for vaping to be accepted as a compelling alternative to smoking, public health institutions should unambiguously and accurately inform smokers who would otherwise continue to smoke that switching completely to vaping can reduce their health risks.*†
Dr David O’Reilly, Director of Scientific Research at BAT, said: “The scientific evidence is clear – but consumer misperceptions remain. In England and the United States, only one in three adults is aware that there is scientific evidence available, including from leading public health authorities, that supports the conclusion that vaping is less harmful than smoking.*†
“The reality is that many leading public health authorities have reported that vaping is less harmful than smoking, and that this harm reduction potential can be maximised if those smokers who would otherwise continue to smoke switch exclusively to using vapour products.”
*Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive
† Our products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
1. Camacho, Oscar M., Ebajemito, James K., Coburn, Steven, Prasad, Krishna, Costigan, Sandra and Murphy, James J. "Evidence From the Scientific Assessment of Electronic Cigarettes and Their Role in Tobacco Harm Reduction" Contributions to Tobacco & Nicotine Research, vol.30, no.2, 2021, pp.63-108. View link
2. McNeill et al. London: Public Health England, 2015.
3. McNeill et al. London: Public Health England, 2020.
4. National Academies of Sciences Engineering and Medicine Public health consequences of e-cigarettes. Washington, DC: National Academies Press, 2018.